2
cc : UCLA Cha n ce ll or Ge n e Bloc k UCLA Boa rd of Reg en t Cha ir m an She r ry Lan sin g S ; ! l I:_ZJ Sha r on K. Fri end, MS, CIP Director Off ice of the Hum an Research Prot ec t ion Prog ram Once ag ain ,t ha nk yo u fo r yo ur le t t er an d ex pr essi ng yo ur co nc er ns. It is re gr et t ab le t ha t t he Hei m lich Inst it ut e an d Dr . Hei m lich co nt in ue to exagge ra t e UCLA's inv olv em ent in m alar iat herap y resear ch. Nev ert hel ess, aft er car efu lly con side ring you r let t er, we ha ve de t er m ined t ha t it is no t ne ce ssar y, ap pr op ri at e, or useful to re -op en t he pa st 10 year old in ve st ig at io n or in it iat e an ot he r re vi ew . We co nside r t his ca se clo sed . Dr . Fah ey re t ir ed fr om t h e Un iv er sit y in 20 08 and no lo ng er li v es inthe st at e. The Uni ve r sit y n o lon ge r ha s any u ri sdi ct ion ov er Dr . Fahey or t he othe r pa rt ie s re fe re nc ed in yo ur le t t er . Aft er co nf er ri ng w ith m y co lle ag ue sI ca n assure you tha t UCLA's revi ew , t ak in g pl ace ov er m or e t han 18 months, w as t ho ro ug h an d ex ha ust iv e an d ba sed on info rm at io n available atth e t ime. The fi ndin gs di d not sup po rt eit her t he Hei m lic h Inst itute's or Dr . Heimlic h' s cla im s t ha t Dr . J ohn Fahe y wa s di re ct ly in volv ed in developin g or co nd uc t in g t he cli ni cal t ri al yo u re fe re nc e. Rathe r, UCLA fo un d t hat Dr . Fahe y w as in vo lv ed in ev alu at in g data an d bi olo gi ca l sam pl es br ou gh t fr om Chin a t o UCLA by an in di vi dual pa rt ici pa t in g in t he Foga rt y Int er nat io na l Prog ra m , and tha t t hi s di d, in fa ct , co nst itut e human sub je ct s re sea rc h t ha t ha d no t be en re vi ewed an d app rov ed as re qu ire d by fed era l reg ula t ion and cam pu s po licy . The cam pu s fol low ed t hrough on its co m m it m en t t o re po rt Dr . Fahe y' s vi ola t ion of fe de ra l an d cam pu s po lic ies t o t he U.S. Dep ar t m ent of Hea lt h an d Hum an Serv ice s, an d t he t hen Exec ut iv e Vice Chan ce llor took st ep s to ensure th at cam pu s rese ar che rs we re re m ind ed of pol ices govern ing hu m an sub ject s research. Tha nk yo u fo r d et ai le d le t t er of Ma y 6 , 2013 , re ga rd in g UCLA' s 2002/2003 inve stig at ion of the Heiml ich Instit ut e's "m alariath erap y" resear ch in China. Dea r Mr. Hei m lic h, Peter M, Hei m lic h 36 30 Riv er Ho ll ow Run Du luth, GA 30096 May16,2013 O F F IC E O F T H E H U M AN R E S E A R C H P R O T E C T IO N P R O G R A M 1 10 00 K I N R O S S A V E N U E , S U I T E 2 11 LOSANGELES , CA 90095-1694 SANTA B AR BARA S ANTA CRUZ UCLA BERKELEY DAVIS IRVINE LOS ANGELES MERCED RIVERSIDE SANDIEGO SANFRANCISCO UNIVERSITY OF CALI F ORNI A, LOS A GELE

5/16/13 reply from UCLA to my 5/6/13 investigations request re: university researchers' role in the Heimlich Institute's "malariotherapy" experiments on AIDS patients in China

Embed Size (px)

Citation preview

Page 1: 5/16/13 reply from UCLA to my 5/6/13 investigations request re: university researchers' role in the Heimlich Institute's "malariotherapy" experiments on AIDS patients in China

7/30/2019 5/16/13 reply from UCLA to my 5/6/13 investigations request re: university researchers' role in the Heimlich Institute's "malariotherapy" experiments on AIDS patients in China

http://slidepdf.com/reader/full/51613-reply-from-ucla-to-my-5613-investigations-request-re-university 1/1